Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ipratropium Bromide Spray for Allergic Rhinitis
IRCT20230522058254N1Phase 3Completed
- Sponsor
- Ideh Darou Teb
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ipratropium bromide in allergic rhinitis (AR), sponsored by Ideh Darou Teb. Started Dec 2024; status: completed.
02
Drugs
ipratropium bromide
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on IRCT20230522058254N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230522058254N1.